Pharmaco-invasive Therapy: A Continued Role for Fibrinolysis in the Primary PCI era
Introduction Early Primary percutaneous coronary intervention (pPCI) is the preferred reperfusion therapy for most patients with ST-segment elevation myocardial infarction (STEMI), and the European guidelines recommend pPCI to occur within 120 min of first medical contact. However, this is not alway...
Main Authors: | Salma Bouyaddid MD, Amine Bouchlarhem MD, Zakaria Bazid MD, Nabila ismaili MD, Noha El ouafi MD |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2023-12-01
|
Series: | Clinical and Applied Thrombosis/Hemostasis |
Online Access: | https://doi.org/10.1177/10760296231221549 |
Similar Items
-
Cardiac intensive care unit: where we are in 2023
by: Amine Bouchlarhem, et al.
Published: (2023-11-01) -
Usefulness of the Quick-Sepsis Organ Failure Assessment Score in Cardiovascular Intensive Care Unit to Predict Prognosis in Acute Coronary Syndrome
by: Amine Bouchlarhem MD, et al.
Published: (2023-12-01) -
One-Year Prognosis Difference of Myocardial Infarction With or Without Coronary Obstruction in Developing Countries: Insights From the Moroccan Experience
by: Amine Bouchlarhem, et al.
Published: (2024-09-01) -
Is There a Causal Link Between Acute Myocarditis and COVID-19 Vaccination: An Umbrella Review of Published Systematic Reviews and Meta-Analyses
by: Amine Bouchlarhem, et al.
Published: (2024-01-01) -
The Efficacy and Safety of Prolonged Oral Anticoagulation for the Prevention of Thromboembolic Events in Patients
Recovered From COVID-19 1 Year
After Hospital Discharge: The SARCOV-19 Prospective Registry
by: Ghizlane El Aidouni, et al.
Published: (2023-02-01)